Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_assertion type Assertion NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_head.
- NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_assertion description "[Our results demonstrate that combined inhibition of MEK and PI3K/mTOR is a rational strategy for the treatment of high-grade gliomas and may be an effective adjuvant therapy for this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_provenance.
- NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_assertion evidence source_evidence_literature NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_provenance.
- NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_assertion SIO_000772 21057530 NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_provenance.
- NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_assertion wasDerivedFrom befree-2016 NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_provenance.
- NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_assertion wasGeneratedBy ECO_0000203 NP850918.RABQdFi8NKX4JpoJ-2jdg4cztB6UNBY36Hm-PFjeHTfK8130_provenance.